They include Rajesh Subramaniam of FedEx, Bill Winters of Standard Chartered, Paul Hudson of Sanofi, and Pascal Soriot of ...

AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker scrambles to revive business in its second-biggest market after scandals including ...

HONG KONG, LONDON] Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the British pharmaceutical giant has tried to maintain a business-as-usual ...

Multinational pharmaceutical company AstraZeneca is bullish about China's role as a global innovation powerhouse, underpinned by the country's sound prospects as well as its growing innovation ...

Cambridge-headquartered AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global strategic R & D centre ...

Pascal Soriot, CEO of British pharmaceutical giant AstraZeneca, discusses the company's $2.5 billion investment in a new China research and development center. Musk to Receive Top-Secret Briefing ...

Today, China is a leading contributor to global economic growth, having the world’s largest middle-income group and a sound ...

Multinational pharmaceutical company AstraZeneca is bullish about China's role as a global innovation powerhouse, underpinned ...

Investing.com -- AstraZeneca (NASDAQ: AZN) Plc’s Chief Executive Officer, Pascal Soriot, has warned that Europe is rapidly losing its pharmaceutical innovation edge to China. He voiced his concerns ...

S&P Global said the UK's dominant services sector, which includes everything from hotels to accountants and hairdressers, ...

The United States doubled down on its decades-old support for Taiwan as China flexed its muscles with a second day of ...